Abstract
A smartphone-based colorimetric reader (SBCR), comprising a Samsung Galaxy SIII mini, a gadget (iPAD mini, iPAD4, or iPhone 5s) and a custom-made dark hood and base holder assembly, is used for human C-reactive protein (CRP) immunoassay. A 96-well microtiter plate (MTP) is positioned on the gadget’s screensaver to provide white light-based bottom illumination only in the specific regions corresponding to the well’s bottom. The images captured by the smartphone’s back camera are analyzed by a novel image processing algorithm. Based on one-step kinetics-based human C-reactive protein immunoassay (IA), SBCR is evaluated and compared with a commercial MTP reader (MTPR). For analysis of CRP spiked in diluted human whole blood and plasma as well as CRP in clinical plasma samples, SBCR exhibits the same precision, dynamic range, detection limit, and sensitivity as MTPR for the developed IA (DIA). Considering its compactness, low cost, advanced features and a remarkable computing power, SBCR is an ideal point-of-care (POC) colorimetric detection device for the next-generation of cost-effective POC testing (POCT).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vashist SK, Mudanyali O, Schneider EM et al (2014) Cellphone-based devices for bioanalytical sciences. Anal Bioanal Chem 406:3263–3277
http://www.itu.int/en/ITU-D/Statistics/Documents/publications/mis2013/MIS2013_without_Annex_4.pdf. Accessed 8 June 2015
Vashist SK, Schneider EM, Luong JHT (2014) Commercial smartphone-based devices and smart applications for personalized healthcare monitoring and management. Diagnostics 4:104–128
Ozcan A (2014) Mobile phones democratize and cultivate next-generation imaging, diagnostics and measurement tools. Lab Chip 14:3187–3194
Vashist SK, van Oordt T, Schneider EM et al (2015) A smartphone-based colorimetric reader for bioanalytical applications using the screen-based bottom illumination provided by gadgets. Biosens Bioelectron 67:248–255
Vashist SK, Schneider EM, Zengerle R et al (2015) Graphene-based rapid and highly-sensitive immunoassay for C-reactive protein using a smartphone-based colorimetric reader. Biosens Bioelectron 66:169–176
Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104–111
Chiesa C, Natale F, Pascone R et al (2011) C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 412:1053–1059
Chiesa C, Panero A, Osborn JF et al (2004) Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 50:279–287
Dollner H, Vatten L, Austgulen R (2001) Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 54:1251–1257
Nguyen-Vermillion A, Juul SE, McPherson RJ et al (2011) Time course of C-reactive protein and inflammatory mediators after neonatal surgery. J Pediatr 159:121–126
Tappero E, Johnson P (2010) Laboratory evaluation of neonatal sepsis. Newborn Infant Nurs Rev 10:209–217
http://www.nomidalliance.org/downloads/comparative_chart_front.pdf. Accessed 8 June 2015
Danner M, Kasl SV, Abramson JL et al (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347–356
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31
Spitzer C, Barnow S, Volzke H et al (2010) Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J Psychiatr Res 44:15–21
Lin MS, Shih SR, Li HY et al (2007) Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men. Diabetes Res Clin Pract 77:286–292
Morimoto H, Sakata K, Oishi M et al (2013) Effect of high-sensitivity C-reactive protein on the development of diabetes as demonstrated by pooled logistic-regression analysis of annual health-screening information from male Japanese workers. Diabetes Metab 39:27–33
Testa R, Bonfigli AR, Sirolla C et al (2008) C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position −675 of the PAI-1 gene. Nutr Metab Cardiovasc Dis 18:220–226
Kuo HK, Yen CJ, Chen JH et al (2007) Association of cardiorespiratory fitness and levels of C-reactive protein: data from the National Health and Nutrition Examination Survey 1999–2002. Int J Cardiol 114:28–33
Park HE, Cho GY, Chun EJ et al (2012) Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization. Atherosclerosis 224:201–207
Ridker PM (2003) High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92:17K–22K
Sicras-Mainar A, Rejas-Gutierrez J, Navarro-Artieda R et al (2013) C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice. Eur Psychiatry 28:161–167
Wilson AM, Ryan MC, Boyle AJ (2006) The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 106:291–297
Acknowledgments
We thank PD Dr. Eberhard Barth for providing the leftover anonymized EDTA plasma samples of patients treated by intensive care at University Hospital Ulm, Germany for validating the DIA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Venkatesh, A.G. et al. (2017). A Smartphone-Based Colorimetric Reader for Human C-Reactive Protein Immunoassay. In: Rasooly, A., Prickril, B. (eds) Biosensors and Biodetection. Methods in Molecular Biology, vol 1571. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6848-0_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6848-0_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6846-6
Online ISBN: 978-1-4939-6848-0
eBook Packages: Springer Protocols